English

BIOSEARCH MEDICAL PRODUCTS INC

EDGAR

Filing (10QSB) · filed 1999-11-15

24 filing records in this dataset, filed from 1996-08-14 to 1999-11-15. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

371 thousand USD

1999-09-30 · USD

Exact inputs and evidence

Revenue: 370685 USD Source

Operating margin

-40.5%

1999-09-30 · %

Exact inputs and evidence

Operating Income: -150135 USD Source
Revenue: 370685 USD Source

Operating cash flow

-46.8 thousand USD

1999-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -533434 USD Source
Operating Cash Flow: -486665 USD Source

Free cash flow

-53.8 thousand USD

1999-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -533434 USD Source
Operating Cash Flow: -486665 USD Source
Capital Expenditure: 12128 USD Source
Capital Expenditure: 5126 USD Source

Cash and cash equivalents: 10.2 thousand USD 1999-09-30 Source
Exact value

10206 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

1.21 million USD

1998-10-01 – 1999-09-30

Exact inputs and evidence

Revenue: 1294838 USD · 1998-01-01 – 1998-12-31 Source
Revenue: 1171351 USD · 1998-01-01 – 1998-09-30 Source
Revenue: 218401 USD · 1999-01-01 – 1999-03-31 Source
Revenue: 498074 USD · 1999-04-01 – 1999-06-30 Source
Revenue: 370685 USD · 1999-07-01 – 1999-09-30 Source

Net income

-56 thousand USD

1998-10-01 – 1999-09-30

Exact inputs and evidence

Net income: -850976 USD · 1998-01-01 – 1998-12-31 Source
Net income: -456278 USD · 1998-01-01 – 1998-09-30 Source
Net income: 400391 USD · 1999-01-01 – 1999-03-31 Source
Net income: 88442 USD · 1999-04-01 – 1999-06-30 Source
Net income: -150125 USD · 1999-07-01 – 1999-09-30 Source

Operating cash flow

-870 thousand USD

1998-10-01 – 1999-09-30

Exact inputs and evidence

Operating cash flow: 96571 USD · 1998-01-01 – 1998-12-31 Source
Operating cash flow: 111112 USD · 1998-01-01 – 1998-09-30 Source
Operating cash flow: -304577 USD · 1999-01-01 – 1999-03-31 Source
Operating cash flow: -504577 USD · 1999-04-01 – 1999-06-30 Source
Operating cash flow: -533434 USD · 1999-01-01 – 1999-09-30 Source
Operating cash flow: -486665 USD · 1999-01-01 – 1999-06-30 Source

Capital expenditure

12.9 thousand USD

1998-10-01 – 1999-09-30

Exact inputs and evidence

Capital expenditure: 5289 USD · 1998-01-01 – 1998-12-31 Source
Capital expenditure: 3488 USD · 1998-01-01 – 1998-09-30 Source
Capital expenditure: 2034 USD · 1999-01-01 – 1999-03-31 Source
Capital expenditure: 2034 USD · 1999-04-01 – 1999-06-30 Source
Capital expenditure: 12128 USD · 1999-01-01 – 1999-09-30 Source
Capital expenditure: 5126 USD · 1999-01-01 – 1999-06-30 Source

Free cash flow

-883 thousand USD

1998-10-01 – 1999-09-30

Exact inputs and evidence

Operating cash flow: 96571 USD · 1998-01-01 – 1998-12-31 Source
Operating cash flow: 111112 USD · 1998-01-01 – 1998-09-30 Source
Operating cash flow: -304577 USD · 1999-01-01 – 1999-03-31 Source
Operating cash flow: -504577 USD · 1999-04-01 – 1999-06-30 Source
Operating cash flow: -533434 USD · 1999-01-01 – 1999-09-30 Source
Operating cash flow: -486665 USD · 1999-01-01 – 1999-06-30 Source
Capital expenditure: 5289 USD · 1998-01-01 – 1998-12-31 Source
Capital expenditure: 3488 USD · 1998-01-01 – 1998-09-30 Source
Capital expenditure: 2034 USD · 1999-01-01 – 1999-03-31 Source
Capital expenditure: 2034 USD · 1999-04-01 – 1999-06-30 Source
Capital expenditure: 12128 USD · 1999-01-01 – 1999-09-30 Source
Capital expenditure: 5126 USD · 1999-01-01 – 1999-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 1999-11-15.

Financial data available through: 1998-12-31.

Coverage by financial measure

Revenue: 5 of 11 periods available· newest 1998-12-31
Operating income: 5 of 11 periods available· newest 1998-12-31
Net income: 5 of 11 periods available· newest 1998-12-31
Operating cash flow: 5 of 11 periods available· newest 1998-12-31
Capital expenditure: 5 of 11 periods available· newest 1998-12-31
Total assets: 4 of 11 periods available· newest 1998-12-31
Total liabilities: 4 of 11 periods available· newest 1998-12-31
Current assets: 4 of 11 periods available· newest 1998-12-31
Current liabilities: 4 of 11 periods available· newest 1998-12-31
Cash and cash equivalents: 5 of 11 periods available· newest 1998-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-33.1%

Prior period

USD 1.94 million

1997-01-01 – 1997-12-31
Current period

USD 1.29 million

1998-01-01 – 1998-12-31

Exact inputs and evidence

1294838 − 1936171 = -641333 USD

1936171 USD · 1997-01-01 – 1997-12-31
Inspect prior input Prior source
1294838 USD · 1998-01-01 – 1998-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · BIOSEARCH MEDICAL PRODUCTS INC · 1998-12-31 BIOSEARCH MEDICAL PRODUCTS INC (edgar:350646) Year-over-year change in Revenue: -641333 USD Concept: fundies:Revenue Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/350646?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 1294838 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/350646/0000950110-99-001208.txt#1643 Input fundies:Revenue: 1936171 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/350646/0000950110-99-001208.txt#1643
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 294,766

Prior period

−USD 556,210

1997-01-01 – 1997-12-31
Current period

−USD 850,976

1998-01-01 – 1998-12-31

Exact inputs and evidence

-850976 − -556210 = -294766 USD

-556210 USD · 1997-01-01 – 1997-12-31
Inspect prior input Prior source
-850976 USD · 1998-01-01 – 1998-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · BIOSEARCH MEDICAL PRODUCTS INC · 1998-12-31 BIOSEARCH MEDICAL PRODUCTS INC (edgar:350646) Year-over-year change in Net income: -294766 USD Concept: fundies:NetIncome Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/350646?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -850976 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/350646/0000950110-99-001208.txt#1810 Input fundies:NetIncome: -556210 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/350646/0000950110-99-001208.txt#1810
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 406,387

Prior period

−USD 309,816

1997-01-01 – 1997-12-31
Current period

USD 96,571

1998-01-01 – 1998-12-31

Exact inputs and evidence

96571 − -309816 = 406387 USD

-309816 USD · 1997-01-01 – 1997-12-31
Inspect prior input Prior source
96571 USD · 1998-01-01 – 1998-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · BIOSEARCH MEDICAL PRODUCTS INC · 1998-12-31 BIOSEARCH MEDICAL PRODUCTS INC (edgar:350646) Year-over-year change in Operating cash flow: 406387 USD Concept: fundies:OperatingCashFlow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/350646?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 96571 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/350646/0000950110-99-001208.txt#1828 Input fundies:OperatingCashFlow: -309816 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/350646/0000950110-99-001208.txt#1828
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-84.7%

Prior period

USD 34,593

1997-01-01 – 1997-12-31
Current period

USD 5,289

1998-01-01 – 1998-12-31

Exact inputs and evidence

5289 − 34593 = -29304 USD

34593 USD · 1997-01-01 – 1997-12-31
Inspect prior input Prior source
5289 USD · 1998-01-01 – 1998-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · BIOSEARCH MEDICAL PRODUCTS INC · 1998-12-31 BIOSEARCH MEDICAL PRODUCTS INC (edgar:350646) Year-over-year change in Capital expenditure: -29304 USD Concept: fundies:CapitalExpenditure Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/350646?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 5289 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/350646/0000950110-99-001208.txt#1833 Input fundies:CapitalExpenditure: 34593 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/350646/0000950110-99-001208.txt#1833
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

1998 1998-01-01 – 1998-12-31

Revenue USD 1.29 million 100% of revenue
Operating costs Derived USD 2.13 million 165% of revenue
Operating income −USD 835,455 −65% of revenue
Tax, interest and other Derived USD 15,521 1.2% of revenue
Net income −USD 850,976 −66% of revenue

Cash

Operating cash flow USD 96,571 7.5% of revenue
Capital expenditure USD 5,289 0.4% of revenue
Free cash flow Derived USD 91,282 7% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1994 Operating loss: operating costs were 122% of revenue.
1995 Operating loss: operating costs were 126% of revenue.
1996 Operating loss: operating costs were 131% of revenue.
1997 Operating loss: operating costs were 125% of revenue.
1998 Operating loss: operating costs were 165% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1994 1994-01-01 – 1994-12-31	3573877	4361448 Derived	-787571	-3738154 Derived	2950583	-998987 Derived	Source 1994-01-01 – 1994-12-31: 3573877 USD Inspect Revenue Open source 1994-01-01 – 1994-12-31: -787571 USD Inspect Operating Income Open source 1994-01-01 – 1994-12-31: 2950583 USD Inspect Net Income Open source 1994-01-01 – 1994-12-31: -970878 USD Inspect Operating Cash Flow Open source 1994-01-01 – 1994-12-31: 28109 USD Inspect Capital Expenditure Open source
1995 1995-01-01 – 1995-12-31	3268220	4110244 Derived	-842024	1608 Derived	-843632	-583246 Derived	Source 1995-01-01 – 1995-12-31: 3268220 USD Inspect Revenue Open source 1995-01-01 – 1995-12-31: -842024 USD Inspect Operating Income Open source 1995-01-01 – 1995-12-31: -843632 USD Inspect Net Income Open source 1995-01-01 – 1995-12-31: -484746 USD Inspect Operating Cash Flow Open source 1995-01-01 – 1995-12-31: 98500 USD Inspect Capital Expenditure Open source
1996 1996-01-01 – 1996-12-31	2648719	3461507 Derived	-812788	70780 Derived	-883568	-929664 Derived	Source 1996-01-01 – 1996-12-31: 2648719 USD Inspect Revenue Open source 1996-01-01 – 1996-12-31: -812788 USD Inspect Operating Income Open source 1996-01-01 – 1996-12-31: -883568 USD Inspect Net Income Open source 1996-01-01 – 1996-12-31: -757484 USD Inspect Operating Cash Flow Open source 1996-01-01 – 1996-12-31: 172180 USD Inspect Capital Expenditure Open source
1997 1997-01-01 – 1997-12-31	1936171	2429538 Derived	-493367	62843 Derived	-556210	-344409 Derived	Source 1997-01-01 – 1997-12-31: 1936171 USD Inspect Revenue Open source 1997-01-01 – 1997-12-31: -493367 USD Inspect Operating Income Open source 1997-01-01 – 1997-12-31: -556210 USD Inspect Net Income Open source 1997-01-01 – 1997-12-31: -309816 USD Inspect Operating Cash Flow Open source 1997-01-01 – 1997-12-31: 34593 USD Inspect Capital Expenditure Open source
1998 1998-01-01 – 1998-12-31	1294838	2130293 Derived	-835455	15521 Derived	-850976	91282 Derived	Source 1998-01-01 – 1998-12-31: 1294838 USD Inspect Revenue Open source 1998-01-01 – 1998-12-31: -835455 USD Inspect Operating Income Open source 1998-01-01 – 1998-12-31: -850976 USD Inspect Net Income Open source 1998-01-01 – 1998-12-31: 96571 USD Inspect Operating Cash Flow Open source 1998-01-01 – 1998-12-31: 5289 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 1.3M 1998

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19941994-12-31	Revenue	3573877	Revenue: 3573877 Open source
19951995-12-31	Revenue	3268220	Revenue: 3268220 Open source
19961996-12-31	Revenue	2648719	Revenue: 2648719 Open source
19971997-12-31	Revenue	1936171	Revenue: 1936171 Open source
19981998-12-31	Revenue	1294838	Revenue: 1294838 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-33.1% 1998

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19941994-12-31	Year over year	No prior comparable period	Revenue: 3573877 Open source
19951995-12-31	Year over year	-8.6%	Revenue: 3268220 Open source Revenue: 3573877 Open source
19961996-12-31	Year over year	-19%	Revenue: 2648719 Open source Revenue: 3268220 Open source
19971997-12-31	Year over year	-26.9%	Revenue: 1936171 Open source Revenue: 2648719 Open source
19981998-12-31	Year over year	-33.1%	Revenue: 1294838 Open source Revenue: 1936171 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -64.5% 1998

Net margin -65.7% 1998

Free cash flow margin 7% 1998

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
19941994-12-31	Operating margin	-22%	Operating Income: -787571 Open source Revenue: 3573877 Open source
19951995-12-31	Operating margin	-25.8%	Operating Income: -842024 Open source Revenue: 3268220 Open source
19961996-12-31	Operating margin	-30.7%	Operating Income: -812788 Open source Revenue: 2648719 Open source
19971997-12-31	Operating margin	-25.5%	Operating Income: -493367 Open source Revenue: 1936171 Open source
19981998-12-31	Operating margin	-64.5%	Operating Income: -835455 Open source Revenue: 1294838 Open source
19941994-12-31	Net margin	82.6%	Net Income: 2950583 Open source Revenue: 3573877 Open source
19951995-12-31	Net margin	-25.8%	Net Income: -843632 Open source Revenue: 3268220 Open source
19961996-12-31	Net margin	-33.4%	Net Income: -883568 Open source Revenue: 2648719 Open source
19971997-12-31	Net margin	-28.7%	Net Income: -556210 Open source Revenue: 1936171 Open source
19981998-12-31	Net margin	-65.7%	Net Income: -850976 Open source Revenue: 1294838 Open source
19941994-12-31	Free cash flow margin	-28%	Revenue: 3573877 Open source Operating Cash Flow: -970878 Open source Capital Expenditure: 28109 Open source
19951995-12-31	Free cash flow margin	-17.8%	Revenue: 3268220 Open source Operating Cash Flow: -484746 Open source Capital Expenditure: 98500 Open source
19961996-12-31	Free cash flow margin	-35.1%	Revenue: 2648719 Open source Operating Cash Flow: -757484 Open source Capital Expenditure: 172180 Open source
19971997-12-31	Free cash flow margin	-17.8%	Revenue: 1936171 Open source Operating Cash Flow: -309816 Open source Capital Expenditure: 34593 Open source
19981998-12-31	Free cash flow margin	7%	Revenue: 1294838 Open source Operating Cash Flow: 96571 Open source Capital Expenditure: 5289 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 96.6K 1998

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19941994-12-31	Operating cash flow	-970878	Operating Cash Flow: -970878 Open source
19951995-12-31	Operating cash flow	-484746	Operating Cash Flow: -484746 Open source
19961996-12-31	Operating cash flow	-757484	Operating Cash Flow: -757484 Open source
19971997-12-31	Operating cash flow	-309816	Operating Cash Flow: -309816 Open source
19981998-12-31	Operating cash flow	96571	Operating Cash Flow: 96571 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 91.3K 1998

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19941994-12-31	Free cash flow	-998987	Operating Cash Flow: -970878 Open source Capital Expenditure: 28109 Open source
19951995-12-31	Free cash flow	-583246	Operating Cash Flow: -484746 Open source Capital Expenditure: 98500 Open source
19961996-12-31	Free cash flow	-929664	Operating Cash Flow: -757484 Open source Capital Expenditure: 172180 Open source
19971997-12-31	Free cash flow	-344409	Operating Cash Flow: -309816 Open source Capital Expenditure: 34593 Open source
19981998-12-31	Free cash flow	91282	Operating Cash Flow: 96571 Open source Capital Expenditure: 5289 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

90.1% 1998

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1994-12-31	Liabilities / assets	Not reported	No source recorded
19951995-12-31	Liabilities / assets	31.3%	Total Liabilities: 1084032 Open source Total Assets: 3463874 Open source
19961996-12-31	Liabilities / assets	40.5%	Total Liabilities: 1016868 Open source Total Assets: 2513224 Open source
19971997-12-31	Liabilities / assets	55.6%	Total Liabilities: 1177083 Open source Total Assets: 2117229 Open source
19981998-12-31	Liabilities / assets	90.1%	Total Liabilities: 807828 Open source Total Assets: 896998 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.91× 1998

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
1994-12-31	Current assets / current liabilities	Not reported	No source recorded
19951995-12-31	Current assets / current liabilities	3.55×	Current Assets: 1364234 Open source Current Liabilities: 384510 Open source
19961996-12-31	Current assets / current liabilities	2.96×	Current Assets: 1047839 Open source Current Liabilities: 354134 Open source
19971997-12-31	Current assets / current liabilities	0.64×	Current Assets: 757224 Open source Current Liabilities: 1177083 Open source
19981998-12-31	Current assets / current liabilities	0.91×	Current Assets: 738259 Open source Current Liabilities: 807828 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1994 1994-01-01 – 1994-12-31	USD 2.95 million Exact value Exact value: 2950583 USD 1994-01-01 – 1994-12-31: 2950583 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOSEARCH MEDICAL PRODUCTS INC · 1994-12-31 BIOSEARCH MEDICAL PRODUCTS INC (edgar:350646) Net Income: 2950583 USD Concept: fundies:NetIncome Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/350646/explain?concept=fundies%3ANetIncome&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:NetIncome: 2950583 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/350646/0000950110-97-000639.txt#1597 The citation records this snapshot. The page link may show a newer release later.	−USD 970,878 Exact value Exact value: -970878 USD 1994-01-01 – 1994-12-31: -970878 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOSEARCH MEDICAL PRODUCTS INC · 1994-12-31 BIOSEARCH MEDICAL PRODUCTS INC (edgar:350646) Operating Cash Flow: -970878 USD Concept: fundies:OperatingCashFlow Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/350646/explain?concept=fundies%3AOperatingCashFlow&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -970878 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/350646/0000950110-97-000639.txt#1617 The citation records this snapshot. The page link may show a newer release later.	USD 28,109 Exact value Exact value: 28109 USD 1994-01-01 – 1994-12-31: 28109 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIOSEARCH MEDICAL PRODUCTS INC · 1994-12-31 BIOSEARCH MEDICAL PRODUCTS INC (edgar:350646) Capital Expenditure: 28109 USD Concept: fundies:CapitalExpenditure Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/350646/explain?concept=fundies%3ACapitalExpenditure&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 28109 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/350646/0000950110-97-000639.txt#1622 The citation records this snapshot. The page link may show a newer release later.	−USD 998,987 Calculation and evidence -970878 − 28109 USD Exact free cash flow: -998987 USD 1994-01-01 – 1994-12-31: -970878 USD · Inspect Operating Cash Flow · Source 1994-01-01 – 1994-12-31: 28109 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIOSEARCH MEDICAL PRODUCTS INC · 1994-12-31 BIOSEARCH MEDICAL PRODUCTS INC (edgar:350646) Free cash flow: -998987 USD Concept: free-cash-flow Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/350646?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -970878 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/350646/0000950110-97-000639.txt#1617 Input fundies:CapitalExpenditure: 28109 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/350646/0000950110-97-000639.txt#1622 The citation records this snapshot. The page link may show a newer release later.
1995 1995-01-01 – 1995-12-31	−USD 843,632 Exact value Exact value: -843632 USD 1995-01-01 – 1995-12-31: -843632 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOSEARCH MEDICAL PRODUCTS INC · 1995-12-31 BIOSEARCH MEDICAL PRODUCTS INC (edgar:350646) Net Income: -843632 USD Concept: fundies:NetIncome Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/350646/explain?concept=fundies%3ANetIncome&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:NetIncome: -843632 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/350646/0000950115-98-000733.txt#1714 The citation records this snapshot. The page link may show a newer release later.	−USD 484,746 Exact value Exact value: -484746 USD 1995-01-01 – 1995-12-31: -484746 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOSEARCH MEDICAL PRODUCTS INC · 1995-12-31 BIOSEARCH MEDICAL PRODUCTS INC (edgar:350646) Operating Cash Flow: -484746 USD Concept: fundies:OperatingCashFlow Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/350646/explain?concept=fundies%3AOperatingCashFlow&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -484746 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/350646/0000950115-98-000733.txt#1731 The citation records this snapshot. The page link may show a newer release later.	USD 98,500 Exact value Exact value: 98500 USD 1995-01-01 – 1995-12-31: 98500 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIOSEARCH MEDICAL PRODUCTS INC · 1995-12-31 BIOSEARCH MEDICAL PRODUCTS INC (edgar:350646) Capital Expenditure: 98500 USD Concept: fundies:CapitalExpenditure Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/350646/explain?concept=fundies%3ACapitalExpenditure&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 98500 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/350646/0000950115-98-000733.txt#1736 The citation records this snapshot. The page link may show a newer release later.	−USD 583,246 Calculation and evidence -484746 − 98500 USD Exact free cash flow: -583246 USD 1995-01-01 – 1995-12-31: -484746 USD · Inspect Operating Cash Flow · Source 1995-01-01 – 1995-12-31: 98500 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIOSEARCH MEDICAL PRODUCTS INC · 1995-12-31 BIOSEARCH MEDICAL PRODUCTS INC (edgar:350646) Free cash flow: -583246 USD Concept: free-cash-flow Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/350646?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -484746 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/350646/0000950115-98-000733.txt#1731 Input fundies:CapitalExpenditure: 98500 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/350646/0000950115-98-000733.txt#1736 The citation records this snapshot. The page link may show a newer release later.
1996 1996-01-01 – 1996-12-31	−USD 883,568 Exact value Exact value: -883568 USD 1996-01-01 – 1996-12-31: -883568 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOSEARCH MEDICAL PRODUCTS INC · 1996-12-31 BIOSEARCH MEDICAL PRODUCTS INC (edgar:350646) Net Income: -883568 USD Concept: fundies:NetIncome Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/350646/explain?concept=fundies%3ANetIncome&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:NetIncome: -883568 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/350646/0000950110-99-001208.txt#1810 The citation records this snapshot. The page link may show a newer release later.	−USD 757,484 Exact value Exact value: -757484 USD 1996-01-01 – 1996-12-31: -757484 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOSEARCH MEDICAL PRODUCTS INC · 1996-12-31 BIOSEARCH MEDICAL PRODUCTS INC (edgar:350646) Operating Cash Flow: -757484 USD Concept: fundies:OperatingCashFlow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/350646/explain?concept=fundies%3AOperatingCashFlow&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -757484 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/350646/0000950110-99-001208.txt#1828 The citation records this snapshot. The page link may show a newer release later.	USD 172,180 Exact value Exact value: 172180 USD 1996-01-01 – 1996-12-31: 172180 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIOSEARCH MEDICAL PRODUCTS INC · 1996-12-31 BIOSEARCH MEDICAL PRODUCTS INC (edgar:350646) Capital Expenditure: 172180 USD Concept: fundies:CapitalExpenditure Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/350646/explain?concept=fundies%3ACapitalExpenditure&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 172180 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/350646/0000950110-99-001208.txt#1833 The citation records this snapshot. The page link may show a newer release later.	−USD 929,664 Calculation and evidence -757484 − 172180 USD Exact free cash flow: -929664 USD 1996-01-01 – 1996-12-31: -757484 USD · Inspect Operating Cash Flow · Source 1996-01-01 – 1996-12-31: 172180 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIOSEARCH MEDICAL PRODUCTS INC · 1996-12-31 BIOSEARCH MEDICAL PRODUCTS INC (edgar:350646) Free cash flow: -929664 USD Concept: free-cash-flow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/350646?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -757484 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/350646/0000950110-99-001208.txt#1828 Input fundies:CapitalExpenditure: 172180 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/350646/0000950110-99-001208.txt#1833 The citation records this snapshot. The page link may show a newer release later.
1997 1997-01-01 – 1997-12-31	−USD 556,210 Exact value Exact value: -556210 USD 1997-01-01 – 1997-12-31: -556210 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOSEARCH MEDICAL PRODUCTS INC · 1997-12-31 BIOSEARCH MEDICAL PRODUCTS INC (edgar:350646) Net Income: -556210 USD Concept: fundies:NetIncome Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/350646/explain?concept=fundies%3ANetIncome&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:NetIncome: -556210 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/350646/0000950110-99-001208.txt#1810 The citation records this snapshot. The page link may show a newer release later.	−USD 309,816 Exact value Exact value: -309816 USD 1997-01-01 – 1997-12-31: -309816 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOSEARCH MEDICAL PRODUCTS INC · 1997-12-31 BIOSEARCH MEDICAL PRODUCTS INC (edgar:350646) Operating Cash Flow: -309816 USD Concept: fundies:OperatingCashFlow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/350646/explain?concept=fundies%3AOperatingCashFlow&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -309816 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/350646/0000950110-99-001208.txt#1828 The citation records this snapshot. The page link may show a newer release later.	USD 34,593 Exact value Exact value: 34593 USD 1997-01-01 – 1997-12-31: 34593 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIOSEARCH MEDICAL PRODUCTS INC · 1997-12-31 BIOSEARCH MEDICAL PRODUCTS INC (edgar:350646) Capital Expenditure: 34593 USD Concept: fundies:CapitalExpenditure Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/350646/explain?concept=fundies%3ACapitalExpenditure&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 34593 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/350646/0000950110-99-001208.txt#1833 The citation records this snapshot. The page link may show a newer release later.	−USD 344,409 Calculation and evidence -309816 − 34593 USD Exact free cash flow: -344409 USD 1997-01-01 – 1997-12-31: -309816 USD · Inspect Operating Cash Flow · Source 1997-01-01 – 1997-12-31: 34593 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIOSEARCH MEDICAL PRODUCTS INC · 1997-12-31 BIOSEARCH MEDICAL PRODUCTS INC (edgar:350646) Free cash flow: -344409 USD Concept: free-cash-flow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/350646?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -309816 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/350646/0000950110-99-001208.txt#1828 Input fundies:CapitalExpenditure: 34593 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/350646/0000950110-99-001208.txt#1833 The citation records this snapshot. The page link may show a newer release later.
1998 1998-01-01 – 1998-12-31	−USD 850,976 Exact value Exact value: -850976 USD 1998-01-01 – 1998-12-31: -850976 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOSEARCH MEDICAL PRODUCTS INC · 1998-12-31 BIOSEARCH MEDICAL PRODUCTS INC (edgar:350646) Net Income: -850976 USD Concept: fundies:NetIncome Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/350646/explain?concept=fundies%3ANetIncome&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:NetIncome: -850976 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/350646/0000950110-99-001208.txt#1810 The citation records this snapshot. The page link may show a newer release later.	USD 96,571 Exact value Exact value: 96571 USD 1998-01-01 – 1998-12-31: 96571 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOSEARCH MEDICAL PRODUCTS INC · 1998-12-31 BIOSEARCH MEDICAL PRODUCTS INC (edgar:350646) Operating Cash Flow: 96571 USD Concept: fundies:OperatingCashFlow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/350646/explain?concept=fundies%3AOperatingCashFlow&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 96571 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/350646/0000950110-99-001208.txt#1828 The citation records this snapshot. The page link may show a newer release later.	USD 5,289 Exact value Exact value: 5289 USD 1998-01-01 – 1998-12-31: 5289 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIOSEARCH MEDICAL PRODUCTS INC · 1998-12-31 BIOSEARCH MEDICAL PRODUCTS INC (edgar:350646) Capital Expenditure: 5289 USD Concept: fundies:CapitalExpenditure Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/350646/explain?concept=fundies%3ACapitalExpenditure&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5289 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/350646/0000950110-99-001208.txt#1833 The citation records this snapshot. The page link may show a newer release later.	USD 91,282 Calculation and evidence 96571 − 5289 USD Exact free cash flow: 91282 USD 1998-01-01 – 1998-12-31: 96571 USD · Inspect Operating Cash Flow · Source 1998-01-01 – 1998-12-31: 5289 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIOSEARCH MEDICAL PRODUCTS INC · 1998-12-31 BIOSEARCH MEDICAL PRODUCTS INC (edgar:350646) Free cash flow: 91282 USD Concept: free-cash-flow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 6d1bbb98deab80b40a538703d34d9cc30456096df7432c0abbf374a043a17791 Dimensions: Consolidated View: https://fundies.io/companies/edgar/350646?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 96571 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/350646/0000950110-99-001208.txt#1828 Input fundies:CapitalExpenditure: 5289 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/350646/0000950110-99-001208.txt#1833 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

24 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000350646, 350646, edgar:350646

BIOSEARCH MEDICAL PRODUCTS INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

1998 1998-01-01 – 1998-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation